This document describes a study assessing the feasibility of using a Filtration Assisted Luminometric ELISA (FAL-ELISA) to detect foot-and-mouth disease virus (FMDV) non-structural protein 3B in formulated vaccines. The FAL-ELISA method was able to successfully detect 3B protein that had been spiked into vaccine samples after extraction of the aqueous phase. Validation studies showed the FAL-ELISA could reliably distinguish between positive and negative samples. The researchers concluded that FAL-ELISA has potential for replacing animal testing to evaluate FMD vaccines by allowing detection of non-structural proteins directly in formulated products.